Trials / Completed
CompletedNCT05965063
The Role of Bifidobacterium Intervention in Food Allergic Infants
Evaluation of the Influence of Bifidobacterium on the Infants With Food Allergic
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 180 (actual)
- Sponsor
- Ruijin Hospital · Academic / Other
- Sex
- All
- Age
- 0 Months – 12 Months
- Healthy volunteers
- Accepted
Summary
Infant food protein allergy is the most common allergic disease in children, which can lead to infantile-specific dermatitis, intestinal inflammation, and so on. Dietary avoidance is a common strategy for food protein allergy in infants and young children. However, the hidden etiology of food protein allergy or multiple food allergies often leads to poor efficacy. The aim of this study is to observe the clinical effectiveness of Bifidobacterium intervention on food allergy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Bifidobacterium M-16V | Bifidobacterium M-16V was dosed at 10 billion colony forming unit (CFU) (equal to 6 drops)/day for 12 weeks. |
| OTHER | allergy food avoidance | strict avoidance of the specific allergenic food |
Timeline
- Start date
- 2023-09-01
- Primary completion
- 2024-12-31
- Completion
- 2025-03-31
- First posted
- 2023-07-28
- Last updated
- 2025-04-04
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05965063. Inclusion in this directory is not an endorsement.